Eli Lilly & Co. (NYSE:LLY) announced that the U.S. Food and Drug Administration has approved two low-dose forms of Cialis for use on a daily basis.
Cialis, an anti-impotence drug, will now be available in 2.5 milligram and 5 milligram doses and will allow men more flexibility in the timing of sexual activity.
"In clinical trials, when taken without restrictions on the timing of sexual activity, Cialis for once daily use improved erectile function over the course of therapy," Lilly said in a release.
The low-dose formulations have already been available in parts of Europe but the company warns that even the new reduced dosage makes the medication inappropriate for heart patients who take nitrates. The combination of sildenafil citrate (Viagra), tadalafil (Cialis) or vardenafil (Levitra) with nitrates can dangerously lower blood pressure. In addition, the FDA also recently required that a warning of potential hearing loss be added to the product label.
[Source: Yahoo News]
Comment Preview